Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Ref Type | |||||||||||||
PMID | (35586703) | ||||||||||||
Authors | Sawayama S, Murakami R, Aki M, Kawaguchi Y, Takao Y, Nonogaki H, Goto T, Yamauchi C | ||||||||||||
Title | Efficacy of pazopanib in FGFR1-amplified uterine carcinosarcoma: A case report. | ||||||||||||
|
|||||||||||||
URL | |||||||||||||
Abstract Text | •We reported the use of pazopanib in the treatment of recurrent uterine carcinosarcoma with FGFR1 amplification.•The expert tumor board recommended pazopanib for off-label use based on genetic mutations found in cancer gene panels.•Pazopanib, a multi-tyrosine kinase inhibitor, was effective against recurrent uterine sarcoma with FGFR1 amplification.•Pazopanib maintained the patient's quality of life for a certain period. |